Traditional cancer therapeutics, such as chemotherapies, are often limited by their non-
specific nature, causing harm to non-malignant tissues. Over the past several decades …

Vaccination is still the most cost-effective way to combat infectious illnesses. Conventional
vaccinations may have low immunogenicity and, in most situations, only provide partial …

Glioblastoma (GBM) remains the most lethal malignant tumours. Gboxin, an oxidative
phosphorylation inhibitor, specifically restrains GBM growth by inhibiting the activity of F0F1 …

Nanogels, also termed hydrogel nanoparticles, have the properties and functions of both
nanomaterials and hydrogels. Till date, a considerable number of nanogels have been …

Osteosarcoma, the most common malignant tumor of the bone, seriously influences people's
lives and increases their economic burden. Conventional chemotherapy drugs achieve …

Cancer immunotherapy can effectively inhibit cancer progression by activating the
autoimmune system, with low toxicity and high effectiveness. Some of cancer …

Nanoparticle‐based therapeutic, prevention, and detection modalities have the potential to
greatly impact how diseases are diagnosed and managed in the clinic. With the wide range …

The integration of reactive oxygen species (ROS)-involved photodynamic therapy (PDT) and
chemodynamic therapy (CDT) holds great promise for enhanced anticancer effects. Herein …

Nanovesicles and bio-vesicles (BVs) have emerged as promising tools to achieve targeted
cancer therapy due to their ability to overcome many of the key challenges currently being …

Hydrophilic polymeric networks that are capable of imbibing huge volumes of water and
undergoing swelling and shrinkage suitably to facilitate controlled drug-release are called …